A controlled release matrix formulation for mesalamine was designed and developed to achieve a 24 h release profile. Using compritol 888 ATO (glyceryl behenate) as an inert matrix-forming agent to control the release of mesalamine, formulation granules containing the solid dispersions were investigated. Pectin, a polysaccharide, was used as bacterial dependent polymer for colon targeting. The matrix tablets for these formulations were prepared by direct compression and their in vitro release tests were carried out. A 32 full factorial design was used for optimization by taking the amounts of glyceryl behenate (X1) and pectin (X2) as independent variables and percentage drug released at 2 (Q2), 16 (Q16) and 24 (Q24) h as dependent variables. Drug release from the matrix tablets formulations lasted for over 24 h. Images of the tablet surface and cross-section were characterized by scanning electron microscopy to show the formed pores and channels in the matrices. These may provide the release pathway for the inner embedded drugs. The co-mixing of polysaccharide pectin, into the waxy matrices played a meaningful role in targeting the tablets to colon. The drug release from the novel formulation may be attributed to the diffusion-controlled mechanism. The results of the full factorial design indicated that an optimum amount of compritol ATO 888 and a high amount of pectin favors the colon targeting and controlled release of mesalamine from dosage form.
In vitro controlled release of colon targeted mesalamine from compritol ATO 888 based matrix tablets using factorial design
Jayvadan K. Patel,N. Patel,Shreeraj Shah
Published 2009 in Research in Pharmaceutical Sciences
ABSTRACT
PUBLICATION RECORD
- Publication year
2009
- Venue
Research in Pharmaceutical Sciences
- Publication date
2009-07-01
- Fields of study
Medicine, Materials Science, Chemistry
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-28 of 28 references · Page 1 of 1
CITED BY
Showing 1-16 of 16 citing papers · Page 1 of 1